Clinical Trial Update: Cabazitaxel Activity in Patients With Advanced AdrenoCortical-Carcinoma Progressing After Previous Chemotherapy Lines [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cabazitaxel in patients with advanced adrenocortical carcinoma progressing after prior chemotherapy shows activity. Further results are…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenocortical Carcinoma

Drugs mentioned

• Cabazitaxel (cabazitaxel)

Snippet

Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Conditions: Adrenocortical Carcinoma | Phase 2 | Status: UNKNOWN